Last updated on December 2018

A Study of Two Different Doses of Cabozantinib (XL184) in Progressive Metastatic Medullary Thyroid Cancer


Find a site near you

Start Over

Hui Gan

Heidelberg, Australia
3.44miles
  Connect »

Jeanne Tie

Parkville, Australia
4.79miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.